International Transaction Journal of Engineering, Management, & Applied Sciences & Technologies

Archives

TuEngr+Logo
:: International Transaction Journal of Engineering, Management, & Applied Sciences & Technologies

http://TuEngr.com


ISSN 2228-9860
eISSN 1906-9642
CODEN: ITJEA8


FEATURE PEER-REVIEWED ARTICLE

Vol.13(11)(2022)

  • Approaches to Managing Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus

    Mokhmad-Emi Turkulovich Ilyasov (Stavropol State Medical University, Stavropol, RUSSIA),
    Madina Valerievna Nadgerieva (North Ossetian State Medical Academy, Vladikavkaz, Republic of North Ossetia-Alania, RUSSIA),
    Magomed Adamovich Dautmerzaev (Saratov State Medical University named after Razumovsky, Saratov, RUSSIA),
    Alibek Muratovich Baitemirov (Dagestan State Medical University, Makhachkala, Republic of Dagestan, RUSSIA),
    Daria Alexandrovna Zhezheria, Yuriy Borisovich Fedoseyev (Rostov State Medical University, Rostov-on-Don, RUSSIA),
    Angelina Georgievna Shevchenko (Stavropol State Medical University, Stavropol, RUSSIA),
    Anastasia Stanislavovna Khutatova (Nevinnomyssk City Children's Hospital, Stavropol Region, RUSSIA),
    Kavsarat Kamaldinovna Atagishieva, Zhamilat Arsenovna Abdullaeva (Dagestan State Medical University, Makhachkala, Republic of Dagestan, RUSSIA),
    Elena Valentinovna Svetlakova (Stavropol State Agrarian University, Stavropol, RUSSIA).

    Discipline: Medicine.

    ➤ FullText

    doi: 10.14456/ITJEMAST.2022.211

    Keywords:Type 2 diabetes mellitus; Cardiovascular diseases; Risk factors; Cardiovascular risk management

    Abstract
    Diabetes mellitus is one of the most common diseases, and therefore, this problem is one of the priorities for doctors and healthcare of all countries. Type 2 diabetes mellitus is a chronic disease that leads to the risk of developing cardiovascular complications and pathologies in patients, and, as a result, to high mortality or disability.

    Paper ID: 13A11A

    Cite this article:

    Ilyasov, M.-E.T., Nadgerieva, M.V., Dautmerzaev, M.A., Baitemirov, A.M., Zhezheria, D.A., Fedoseyev, Yu.B., Shevchenko, A.G., Khutatova, A.S., Atagishieva, K.K., Abdullaeva, Zh.A., E.V. Svetlakova (2022). Approaches to Managing Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus. International Transaction Journal of Engineering, Management, & Applied Sciences & Technologies, 13(11), 13A11A, 1-7. http://TUENGR.COM/V13/13A11A.pdf DOI: 10.14456/ITJEMAST.2022.211

References

  1. Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Ryden L, Xavier D. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. The Lancet. 2019 Jul 13;394(10193):121-30.
  2. Gonzalez-Lao E, Corte Z, Simon M, Ricos C, Coskun AB, Braga F, Aarsand AK, Carobene A, Bartlett WA, Boned B, Asland B. Systematic review of the biological variation data for diabetes related analytes. Clinica Chimica Acta. 2019 Jan 1;488:61-7.
  3. Raevskaya AI, Belyalova AA, Shevchenko PP, Karpov SM, Mishvelov AE, Simonov AN, Povetkin SN. COGNITIVE IMPAIRMENTS IN A RANGE OF SOMATIC DISEASES. DIAGNOSTICS, MODERN APPROACH TO THERAPY. people.;22:23.
  4. Bledzhyants GA, Mishvelov AE, Nuzhnaya KV, Anfinogenova OI, Isakova JA, Melkonyan RS, Hite GY, Suprunchuk VE, Makova AV, Popov AN, Ovechkin VS. The effectiveness of the medical decision-making support system" electronic clinical pharmacologist" in the management of patients therapeutic profile. Artificial intelligence. 2019 Apr 28.
  5. Boraeva TT, Vadaeva MA, Matveeva UV, Revazova AB, Albegova BZ, Kanukoeva DT, Mishvelov AE, Povetkin SN. Dynamics of Diseases of the Upper Digestive Tract in Children. Journal of Pharmaceutical Research International. 2021;33(38B):48-57.
  6. Michos ED, McEvoy JW, Blumenthal RS. Lipid management for the prevention of atherosclerotic cardiovascular disease. New England Journal of Medicine. 2019 Oct 17;381(16):1557-67.
  7. Grenier J, Goodman SG, Leiter LA, Langer A, Teoh H, Bhatt DL, Cheng AY, Tan MK, Ransom T, Connelly KA, Yan AT. Blood pressure management in adults with type 2 diabetes: insights from the diabetes mellitus status in Canada (DM-SCAN) survey. Canadian Journal of Diabetes. 2018 Apr 1;42(2):130-7.
  8. Siddiqui SA, Ali Redha A, Snoeck ER, Singh S, Simal-Gandara J, Ibrahim SA, Jafari SM. Anti-Depressant Properties of Crocin Molecules in Saffron. Molecules. 2022 Mar 23;27(7):2076.
  9. Giorgino F, Vora J, Fenici P, Solini A. Renoprotection with SGLT2 inhibitors in type 2 diabetes over a spectrum of cardiovascular and renal risk. Cardiovascular Diabetology. 2020 Dec;19(1):1-9.
  10. Johnson RJ, Bakris GL, Borghi C, Chonchol MB, Feldman D, Lanaspa MA, Merriman TR, Moe OW, Mount DB, Lozada LG, Stahl E. Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the National Kidney Foundation. American Journal of Kidney Diseases. 2018 Jun 1;71(6):851-65.
  11. Mezhidov, B. S., Bekova, K. I., Edieva, A. A., Madalova, K. I., Malakhova, V. A., Uspaeva, Z. A., Tachaeva, M. S., Tsinaeva, A. M., Maslova, A. Y. and Khodisov, S. V. (2021) "Association of Genetic Polymorphism of Tumor Necrosis Factor-? in the Development of Coronary Heart Disease in Elderly Patients", Journal of Pharmaceutical Research International, 33(54B), pp. 81-88. doi: 10.9734/jpri/2021/v33i54B33768
  12. Selimov MA, Nagdalian AA, Povetkin SN, Statsenko EN, Kulumbekova IR, Kulumbekov GR, Litvinov MS, Mishvelov AE, Iraskhanov AS, Abdurashidov AM, Gadzhiev MR. Investigation of CdCl? Influence on Red Blood Cell Morphology. International Journal of Pharmaceutical and Phytopharmacological Research. 2019;9(5):8-13.
  13. Rzhepakovsky I, Anusha Siddiqui S, Avanesyan S, Benlidayi M, Dhingra K, Dolgalev A, Enukashvily N, Fritsch T, Heinz V, Kochergin S, Nagdalian A. Anti?arthritic effect of chicken embryo tissue hydrolyzate against adjuvant arthritis in rats (X?ray microtomographic and histopathological analysis). Food Science & Nutrition. 2021 Oct;9(10):5648-69.
  14. Ungurianu A, Zanfirescu A, Gradinaru D, Ionescu-Tirgoviste C, Danciulescu Miulescu R, Margina D. Interleukins and redox impairment in type 2 diabetes mellitus: mini-review and pilot study. Current Medical Research and Opinion. 2022 Apr 3;38(4):511-22.
  15. Viigimaa M, Sachinidis A, Toumpourleka M, Koutsampasopoulos K, Alliksoo S, Titma T. Macrovascular complications of type 2 diabetes mellitus. Current vascular pharmacology. 2020 Mar 1;18(2):110-6.
  16. Rybak V, Derkach N, Korol V. Modern aspects of sugar-reducing effect of thick bean extract based on a type ii diabetes model on the background of obesity. Georgian medical news. 2019 May 1;5(290):144-9.
  17. Dong N, Gao YH, Liu B, Zhao CW, Yang C, Li SQ, Liu JG, Qi X. Differential expression of adipokines in knee osteoarthritis patients with and without metabolic syndrome. International Orthopaedics. 2018 Jun;42(6):1283-9.
  18. Ayivi R, Ibrahim SA, Colleran H, Silva R, Williams L, Galanakis C, Fidan H, Tomovska J, Siddiqui SA. COVID-19: human immune response and the influence of food ingredients and active compounds. Bioactive Compounds in Health and Disease. 2021 Jun 29;4(6):100-48.
  19. Ranjha MM, Shafique B, Rehman A, Mehmood A, Ali A, Zahra SM, Nasreen S, Singh A, Ibrahim SA, Siddiqui SA. Biocompatible Nanomaterials in Food Science, Technology and Nutrient Drug Delivery: Recent Developments and Applications. Frontiers in Nutrition. 2021 Jan 1:1141.
  20. Sergeevna LM, Ivanovich KV, Sergey P, Viktorovich PS, MarinaPetrovna M, Viktorovich SV, Ashotovich76 NA. 5% Suspension of albendazole echinacea magenta (echinacea purpurea) toxicometric evaluation. Entomology and Applied Science Letters. 2018 Jan 1;5(4):30-4.
  21. Churuangsuk C, Hall J, Reynolds A, Griffin SJ, Combet E, Lean ME. Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission. Diabetologia. 2021 Nov 17:1-23.
  22. Maggio CA, Pi-Sunyer FX. Obesity and type 2 diabetes. Endocrinology and Metabolism Clinics. 2003 Dec 1;32(4):805-22.
  23. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. Journal of the American college of cardiology. 2009 May 26;53(21):1925-32.
  24. Katsiki N, Papanas N, Fonseca VA, Maltezos E, Mikhailidis DP. Uric acid and diabetes: is there a link?. Current pharmaceutical design. 2013 Aug 1;19(27):4930-7.
  25. Areshidze DA, Mischenko DV, Makartseva LA, Kucher SA, Kozlova MA, Timchenko LD, Rzhepakovsky IV, Nagdalian AA, Pushkin SV. Some functional measures of the organism of rats at modeling of ischemic heart disease in two different ways. Entomology and Applied Science Letters. 2018 Jan 1;5(4):19-29.
  26. Lai YJ, Chen YY, Ku PW, Chen LJ, Yen YF. Association between uric acid level and incidence of albuminuria in patients with type 2 diabetes mellitus: A 4.5-year cohort study. Medicine. 2021 Oct 10;100(41).
  27. Lou Y, Qin P, Wang C, Ma J, Peng X, Xu S, Chen H, Zhao D, Wang L, Liu D, Li Y. Sex-specific association of serum uric acid level and change in hyperuricemia status with risk of type 2 diabetes mellitus: a large cohort study in China. Journal of Diabetes Research. 2020 Jul 24;2020.
  28. Bloomgarden Z. Diabetes and branched-chain amino acids: What is the link?. Journal of diabetes. 2018 Feb 13;10(5):350-2.
  29. Kim HS, Shin JA, Lee SH, Kim ES, Cho JH, Son HY, Yoon KH. A comparative study of the effects of a dipeptidyl peptidase-IV inhibitor and sulfonylurea on glucose variability in patients with type 2 diabetes with inadequate glycemic control on metformin. Diabetes technology & therapeutics. 2013 Oct 1;15(10):810-6.
  30. Vinik AI, Nevoret ML, Casellini C, Parson H. Diabetic neuropathy. Endocrinology and Metabolism Clinics. 2013 Dec 1;42(4):747-87.


Other issues:
Vol.13(10)(2022)
Vol.13(9)(2022)
Vol.13(8)(2022)
Archives




Call-for-Papers

Call-for-Scientific Papers
Call-for-Research Papers: ITJEMAST invites you to submit high quality papers for full peer-review and possible publication in areas pertaining engineering, science, management and technology, especially interdisciplinary/cross-disciplinary/multidisciplinary subjects.

To publish your work in the next available issue, your manuscripts together with copyright transfer document signed by all authors can be submitted via email to Editor @ TuEngr.com (please see all detail from Instructions for Authors)



Publication and peer-reviewed process:
After the peer-review process, articles will be on-line published in the available next issue. However, the International Transaction Journal of Engineering, Management, & Applied Sciences & Technologies cannot guarantee the exact publication time as the process may take longer time, subject to peer-review approval and adjustment of the submitted articles.

Disclaimer statement


©2022 All Rights Reserved.